--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Libre by Abbott" developer_entity: "Abbott Labs" bundle_id: "com.abbott.adc.freestyle.libre.us" app_store_id: "6670330506" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-01-16" report_date: "2026-06-10" last_verified: "2026-06-10T00:00:00.000Z" report_version: "1.2.1" total_reviews: 126057 overall_rating: 4.5 sentiment: "Mixed" sentiment_score: 45 confidence: "high" confidence_score: 0.6 top_praise_theme: "Real-time glucose monitoring provides freedom from manual finger-prick testing throughout the day" top_complaint_theme: "Frequent Bluetooth connection drops between the sensor and mobile device disrupt continuous data tracking" review_sample_size: 49 total_review_count: 49 analyzed_review_count: 49 data_age_days: 67 intelligence_version: 3 nemesis: "mySugr - Diabetes Tracker Log" competitor_count: 8 tags: ["medical", "free", "mixed sentiment", "mobile app", "app review", "app analysis", "diabetes", "patients", "(ages"] canonical_url: "https://marlvel.ai/apps/com-abbott-adc-freestyle-libre-us" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Libre by Abbott Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free - **Signal**: Rating 4.53 · Sentiment Mixed - **Recent focus**: Frequent Bluetooth connection drops between the sensor and mobile device disrupt continuous data tracking (top complaint) · Real-time glucose monitoring provides freedom from manual finger-prick testing throughout the day (top praise) > **TL;DR:** Libre by Abbott is a medical app by Abbott Labs, rated 4.53/5 by 126.1K users, with Mixed user sentiment (45/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** Libre by Abbott shows Mixed sentiment (4.53/5 from 126.1K reviews) — users praise real-time glucose monitoring provides freedom from manual finger-prick testing throughout the day but report issues with frequent bluetooth connection drops between the sensor and mobile device disrupt continuous data tracking. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.53/5 (126.1K reviews) | | **User Mood** | Mixed | | **Category** | Medical | | **Developer** | Abbott Labs | | **Pricing** | Free | | **Platforms** | iOS & Android | | **Confidence** | High (0.6/1.0) | | **Data Age** | 67d | ## Metadata & Market Performance - **Publisher:** Abbott Labs - **Category:** Medical - **Target Audience:** Diabetes patients (ages 2+) and their caregivers or healthcare providers. - **Platforms:** iOS & Android - **Version Reviewed:** 1.2.1 - **Report Date:** 2026-06-10 - **Signal Count:** 49 reviews analyzed - **Confidence:** High (0.6/1.0) - **App Store ID (iOS):** 6670330506 - **Bundle ID:** com.abbott.adc.freestyle.libre.us - **Google Play ID:** com.abbott.adc.freestyle.libre.us - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-06-10 - **Short Description:** Continuous Glucose Monitoring ## Executive Snapshot **What it is:** Libre by Abbott is a continuous glucose monitoring app for diabetes patients, serving as a companion tool for proprietary hardware sensors on iOS and Android. **Why users hire it:** Users hire the app to automate glucose tracking and eliminate manual finger-prick testing, shifting the burden of care from active logging to passive, real-time data monitoring. ## App DNA (Features & Intent) - **[Differentiator] Libre Assist:** Generative AI food impact prediction * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior. - **[Standard] Real-time Monitoring:** Automatic glucose readings every minute - **[Differentiator] LibreLinkUp:** Remote data sharing for caregivers ## Market Position {#market-position} Libre by Abbott currently holds the #12 spot in the US Medical category. The gap between its high-utility sensor hardware and the mixed sentiment on connectivity suggests that market share is currently defended by hardware lock-in rather than software satisfaction. ## Monetization Strategy - **Model:** Free - **Tiers:** Free app, Prescription-only sensors - **Analysis:** The app functions as a free utility to drive recurring revenue from prescription-only sensor hardware. ## 🟡 User Sentiment (High Confidence: 49 of 49 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.53/5 - **Platform Split:** iOS 4.6/5 (105.5K ratings) | Android 4.3/5 (20.6K ratings) - **Overall Sentiment:** Mixed ### Top Praises - **Real-time glucose monitoring provides freedom from manual finger-prick testing throughout the day** ### Top Complaints (Impact Areas) - **Frequent Bluetooth connection drops between the sensor and mobile device disrupt continuous data tracking** ## SWOT Analysis {#swot} **Core Strengths:** - Proprietary sensor-hardware integration creates high switching costs - LibreView clinical data management drives provider-led prescription volume **Growth Levers:** - Untapped education partnerships for B2B distribution - Integration of insulin delivery systems for closed-loop management ## Recent Changes (v2 → v3) {#recent-changes} The app introduced AI-driven features and caregiver tools but faces a decline in user trust due to new, persistent Bluetooth connectivity issues. **Overall trend**: Mixed **Compared at**: 2026-06-10 ### High-impact changes - **[Declined] Bluetooth connectivity failures** (sentiment) - **[Added] Libre Assist and LibreLinkUp** (features) ### Medium-impact changes - **[Shifted] Caregiver inclusion** (audience) - **[Shifted] Competitive stance** (positioning) ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### Libre by Abbott vs mySugr - Diabetes Tracker Log - **[mySugr - Diabetes Tracker Log](https://marlvel.ai/apps/com-mysugr-companion-mysugr)** by mySugr GmbH: With over 134,000 reviews and a high release cadence, mySugr is the primary competitor for user engagement in the diabetes management space. - **Key differences:** - Gamified logging experience increases daily user retention compared to this app's clinical-first data entry approach. - Integrates with a wider variety of third-party glucose meters beyond this app's proprietary sensor ecosystem. - Provides comprehensive insulin and carbohydrate tracking features that this app currently lacks. ### Contenders (Strong Challengers) - **[Dexcom G7](https://marlvel.ai/apps/com-dexcom-g7app)** by Dexcom: As a direct competitor in the CGM hardware space, Dexcom G7 is the primary alternative for users choosing between sensor ecosystems. - Hardware-integrated alert system offers more granular customization for glucose thresholds than this app. - Direct integration with insulin delivery systems provides a closed-loop experience that this app currently lacks. - **[OneTouch Reveal® app](https://marlvel.ai/apps/com-lifescan-reveal)** by LifeScan, Inc.: A long-standing competitor in the diabetes space with a massive user base and high-quality clinical data visualization. - Visualizes high-glucose patterns over time to help users identify specific lifestyle triggers more effectively. - Color-coded dashboard provides immediate, at-a-glance status updates for patients and their healthcare providers. - **[Glucose Buddy Diabetes Tracker](https://marlvel.ai/apps/com-oneapponecause-glucosebuddy)** by Azumio Inc.: A veteran tracker that serves as a strong alternative for users who prioritize manual logging and community support. - Includes a robust community forum for peer support which is absent in this app. - Offers extensive reporting tools that allow users to export data for physician review in multiple formats. ### Peers (What They Do Better) - **[Medisafe Medication Management](https://marlvel.ai/apps/com-medisafe-medisafe)** by MediSafe Inc.: Adjacent medical utility that focuses on medication adherence, a critical secondary need for diabetic patients. - Advanced medication reminder system includes family notification features for missed doses, increasing patient safety. - Cross-condition tracking allows users to manage multiple chronic conditions alongside their diabetes management. - **[Kardia](https://marlvel.ai/apps/com-alivecor-professional-aliveecg)** by AliveCor, Inc.: High-utility medical app that demonstrates how to successfully pair hardware with a high-engagement mobile interface. - Provides instant clinical-grade ECG analysis that sets a high bar for medical hardware-app integration. - Subscription-based premium insights model offers a clear path for monetization beyond the free app tier. ### New Kids on the Block (What's Innovative) - **[Sword Health: AI Care](https://marlvel.ai/apps/com-swordhealth-guarda-ios)** by Sword Health, Inc: High-velocity release cadence indicates an aggressive push into AI-driven personalized health coaching. - **[One Medical](https://marlvel.ai/apps/com-onemedical-onemedicalmobile)** by One Medical Group, Inc.: Rapidly evolving platform that bridges the gap between digital tracking and direct access to clinical care. ## App Momentum (Steady) {#momentum} - Shipped Libre Assist AI food prediction. - Enabled direct smartwatch glucose readings. ## The "So What?" (Strategic Takeaway) {#so-what} Libre by Abbott is an established medical app that is completely free. It holds a 4.53/5 rating from 126.1K reviews. > **Bottom Line:** Libre by Abbott maintains its category lead through proprietary hardware, but technical instability in the latest version threatens long-term retention, so the PM must prioritize Bluetooth reliability over new AI features to prevent user migration to more stable competitors. **Best for:** Diabetes patients (ages 2+) and their caregivers or healthcare providers. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Rebuild Bluetooth handshake logic because connection drops are the #1 complaint theme → reduce churn ### Feature Gaps vs Competitors - Gamified logging (available in mySugr) ### Outlook: Mixed The diabetes management market is shifting toward closed-loop systems that prioritize data reliability over standalone tracking. Libre by Abbott remains advantaged by its sensor ecosystem, but the current technical friction creates an opening for rivals to capture the power-user segment. - 🔴 Persistent Bluetooth connectivity failures in the latest version disrupt data tracking, which compounds the rating drag already visible on Android. - 🟢 The addition of Libre Assist AI indicates active feature investment, which differentiates the app from purely manual logging competitors. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.53/5 | | Total Reviews | 126.1K | | Sentiment | Mixed (45/100) | | Confidence | High | | Pricing Model | Free | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Mixed | | Outlook | Mixed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Libre by Abbott** (this app) | 4.53/5 | Mixed | Abbott Labs | | [Sword Health: AI Care](https://marlvel.ai/apps/com-swordhealth-guarda-ios) | 4.7/5 | N/A | Sword Health, Inc | | [Medisafe Medication Management](https://marlvel.ai/apps/com-medisafe-medisafe) | 4.7/5 | n/a | MediSafe Inc. | | [One Medical](https://marlvel.ai/apps/com-onemedical-onemedicalmobile) | 4.9/5 | N/A | One Medical Group, Inc. | | [Kardia](https://marlvel.ai/apps/com-alivecor-professional-aliveecg) | 4.8/5 | N/A | AliveCor, Inc. | | [OneTouch Reveal® app](https://marlvel.ai/apps/com-lifescan-reveal) | 4.8/5 | N/A | LifeScan, Inc. | ## Company Profile - **Developer:** Abbott Labs - **Website:** [https://www.FreeStyleLibre.com](https://www.FreeStyleLibre.com) - **Social:** [Instagram](https://www.instagram.com/freestylediabetes) · [Facebook](https://www.facebook.com/FreeStyleDiabetes) · [X/Twitter](https://twitter.com/FreeStyleDiabet) · [YouTube](https://www.youtube.com/freestyleus) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/libre-by-abbott/id6670330506?uo=2) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.abbott.adc.freestyle.libre.us&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.FreeStyleLibre.com) - **Sources:** Developer website content, App store metadata, User reviews. ## Related Intel Reports - [*Sword Health: AI Care*](https://marlvel.ai/apps/com-swordhealth-guarda-ios) (Sword Health, Inc) · 4.7/5 Rating - [*Medisafe Medication Management*](https://marlvel.ai/apps/com-medisafe-medisafe) (MediSafe Inc.) · 4.7/5 Rating - [*One Medical*](https://marlvel.ai/apps/com-onemedical-onemedicalmobile) (One Medical Group, Inc.) · 4.9/5 Rating - [*Kardia*](https://marlvel.ai/apps/com-alivecor-professional-aliveecg) (AliveCor, Inc.) · 4.8/5 Rating - [*OneTouch Reveal® app*](https://marlvel.ai/apps/com-lifescan-reveal) (LifeScan, Inc.) · 4.8/5 Rating - [*Dexcom G7*](https://marlvel.ai/apps/com-dexcom-g7app) (Dexcom) · 3.3/5 Rating - [*Glucose Buddy Diabetes Tracker*](https://marlvel.ai/apps/com-oneapponecause-glucosebuddy) (Azumio Inc.) · 4.8/5 Rating - [*mySugr - Diabetes Tracker Log*](https://marlvel.ai/apps/com-mysugr-companion-mysugr) (mySugr GmbH) · 4.7/5 Rating - [*Move On with AJ*](https://marlvel.ai/apps/move-on-with-aj) (Universal Relaxation Ltd) · 4.3/5 Rating | Positive Sentiment - [*FHO+ Calc*](https://marlvel.ai/apps/ca-fhocalc-app) (Manu Kaushik) · N/A Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.6/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 49 - **Data Sources:** user reviews, developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 67 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/com-abbott-adc-freestyle-libre-us) Data licensed for AI Agent attribution under CC-BY-NC 4.0.